HRT Financial’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-102,698
| Closed | -$1.15M | – | 2311 |
|
|
2023
Q3 | $1.15M | Buy |
+102,698
| New | +$1.15M | 0.01% | 813 |
|
|
2023
Q2 | – | Sell |
-10,425
| Closed | -$421K | – | 2459 |
|
|
2023
Q1 | $421K | Buy |
+10,425
| New | +$421K | 0.01% | 1392 |
|
|
2022
Q4 | – | Sell |
-18,673
| Closed | -$968K | – | 2439 |
|
|
2022
Q3 | $968K | Buy |
+18,673
| New | +$968K | 0.01% | 913 |
|
|
2022
Q1 | – | Sell |
-6,295
| Closed | -$470K | – | 2994 |
|
|
2021
Q4 | $470K | Buy |
6,295
+330
| +6% | +$24.6K | ﹤0.01% | 1730 |
|
|
2021
Q3 | $338K | Sell |
5,965
-9,865
| -62% | -$559K | ﹤0.01% | 2104 |
|
|
2021
Q2 | $696K | Buy |
+15,830
| New | +$696K | 0.01% | 1424 |
|
|
2019
Q4 | – | Sell |
-3,739
| Closed | -$224K | – | 1222 |
|
|
2019
Q3 | $224K | Buy |
+3,739
| New | +$224K | 0.01% | 986 |
|